Investment analysts at StockNews.com assumed coverage on shares of ARCA biopharma (NASDAQ:ABIO – Get Rating) in a report released on Thursday. The brokerage set a “sell” rating on the biopharmaceutical company’s stock. ARCA biopharma Trading Up 1.4 % Shares of NASDAQ:ABIO opened at $2.11 on Thursday. The business’s fifty day moving average price is $2.06 […]